XBI icon

SPDR S&P Biotech ETF

708 hedge funds and large institutions have $7.19B invested in SPDR S&P Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 227 increasing their positions, 236 reducing their positions, and 95 closing their positions.

Holders
708
Holders Change
-34
Holders Change %
-4.58%
% of All Funds
11.34%
Holding in Top 10
23
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-25.81%
% of All Funds
0.37%
New
75
Increased
227
Reduced
236
Closed
95
Calls
$1.15B
Puts
$1.7B
Net Calls
-$543M
Net Calls Change
-$894M
Name Market Value Shares Shares
Change
Shares
Change %
CASC
801
Coppell Advisory Solutions Corp
Texas
-22 Closed
LS
802
Leelyn Smith
Illinois
-20 Closed
Jones Financial Companies
803
Jones Financial Companies
Missouri
-9 Closed
N
804
Natixis
France
-3 Closed
OSAM
805
O'Shaughnessy Asset Management
Connecticut
-1 Closed
PL
806
Parkwood LLC
Ohio
BM
807
Baymount Management
Florida
UOC
808
UBS O'Connor
Illinois
KSCM
809
Kamunting Street Capital Management
Florida
CAM
810
CenterStar Asset Management
Illinois
BFM
811
Boothbay Fund Management
New York
PA
812
Perceptive Advisors
New York
SCM
813
Soleus Capital Management
Connecticut
JGC
814
J. Goldman & Co
New York
ACM
815
Aquilo Capital Management
California
SCM
816
Suvretta Capital Management
New York
IC
817
Ikarian Capital
Texas
GTC
818
Ghost Tree Capital
New York
TM
819
Triatomic Management
California
GF
820
Greenhouse Funds
Maryland
APM
821
Avidity Partners Management
Texas
ACA
822
Avoro Capital Advisors
New York
Nomura Holdings
823
Nomura Holdings
Japan
CC
824
Centiva Capital
New York
PCM
825
Pentwater Capital Management
Florida